InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Olwill Shane, Directeur du Développement. Insider active across 1 companies, notably Pieris Pharmaceuticals, INC.. Cumulatively, 2 filings have been recorded. The latest transaction was filed on 30 August 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations2 total
€49,47738,400 shares@ €1.2885100.0% of flow
Common Stock
SEC:0001562180-21-005712·
€49,47738,400 shares@ €1.288550.0% of flow
Common Stock
SEC:0001562180-21-005712:0·
2 of 2 declarations
About Olwill Shane
Olwill Shane is the Chief Development Officer at PIERIS PHARMACEUTICALS, INC. He is responsible for product development strategy and innovation. Shane leverages his expertise to identify new opportunities and strengthen the company's market position.
